Pharmaceutical combination
A compound and fragment-binding technology, applied in the field of medicine, can solve problems such as poor curative effect, survival rate less than 30%, and insignificant benefit
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0085] Inclusion criteria:
[0086] 1. Invasive triple-negative breast cancer confirmed by histology (specific definition: immunohistochemical detection of ER<1% tumor cells positive is defined as ER negative, PR<1% tumor cells positive is defined as PR negative, HER20-1+ or HER2 is ++ but negative by FISH or CISH, without amplification, defined as HER2 negative);
[0087] 2. Locally advanced breast cancer (unable to undergo radical local treatment) or recurrent and metastatic breast cancer;
[0088] 3. Refractory triple-negative breast cancer (existing treatments have failed), specific definition: common chemotherapy drugs that can be obtained in China include anthracyclines, taxanes, platinum, capecitabine, gemcitabine and vinorelbine , The above-mentioned commonly used chemical drug treatment fails, the patient's condition has not been effectively controlled before enrollment, and the condition is in progress.
[0089] Dosing regimen (every 4 weeks):
[0090] Drug A, PD-...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com